The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Amdocs Ltd
F:AOS
|
GG |
|
A
|
AES Corp
F:AES
|
US |
|
E-World Co Ltd
KRX:084680
|
KR |
|
Genting Singapore Ltd
F:36T
|
SG |
|
Arla Plast AB
STO:ARPL
|
SE |
|
W
|
Wise Group PLC
NASDAQ:WSE
|
UK |
|
Fisher & Paykel Healthcare Corporation Ltd
F:FPLB
|
NZ |
|
E
|
Emerson Electric Co
F:EMR
|
US |
|
D&L Industries Inc
OTC:DLNDY
|
PH |
|
Coty Inc
NYSE:COTY
|
US |
|
I
|
Intesa Sanpaolo SpA
XMUN:IES
|
IT |
|
Strides Pharma Science Ltd
NSE:STAR
|
IN |
|
Informa PLC
LSE:INF
|
UK |
|
Atresmedia Corporacion de Medios de Comunicacion SA
MAD:A3M
|
ES |
|
AerSale Corp
NASDAQ:ASLE
|
US |
|
T
|
T-Mobile US Inc
F:TM5
|
US |
|
StepStone Group Inc
NASDAQ:STEP
|
US |
|
Lincoln Electric Holdings Inc
NASDAQ:LECO
|
US |
|
Physicians Realty Trust
NYSE:DOC
|
US |
|
D
|
DNF Co Ltd
KOSDAQ:092070
|
KR |
|
Apple Inc
NASDAQ:AAPL
|
US |
|
S
|
SSE PLC
XMUN:SCT
|
UK |
|
C
|
Ciena Corp
XMUN:CIE1
|
US |
|
D
|
Diana Shipping Inc
F:DSZ
|
GR |
Amdocs Ltd (AOS)’s 12-month stock price forecast through October 2027 has a consensus target of €87.18, implying 57% upside. The forecast is based on price targets from 8 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
AOS is 87.18 EUR with a low forecast of 74.04 EUR and a high forecast of 128.29 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 7 years is 4%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 5 years is 5%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 10%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 16%.
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 5 years is 14%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more